First Choice Neurology

First Choice Neurology Research Center 57 Clinical Trials

First Choice Neurology Research Center 57 offers clinical trials for Multiple Sclerosis, Spasticity, Epilepsy, and other neurological disorders.

Multiple Sclerosis Clinical Studies

A Phase 3, 18 months, open-label, multicenter study to assess the effect of Ofatumumab 20mg SC monthly in treatment-naive, very early Relapsing-Remitting Multiple Sclerosis patients benchmarked against healthy controls on select outcomes

A Phase 3 randomized, double-blind study comparing efficacy and safety of frexalimab (SAR441344) to teriflunomide in adult participants with relapsing forms of multiple sclerosis.

EMD Serano
Effectiveness of Switching to Cladribine Tablets in Multiple Sclerosis Patients with High Disease Activity or Disease Breakthrough in a US Real-World Population (HDA Switch Study)

Clinical Trials in Boca Raton

Spasticity Clinical Studies

A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, Crossover Study to Evaluate the Clinical Safety and Efficacy of AbobotulinumtoxinA (Dysport®) in Comparison with OnabotulinumtoxinA (Botox®) when Treating Adults with Upper Limb Spasticity.

Epilepsy Clinical Studies

A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Refractory Focal Onset Epilepsy.

Contact First Choice Neurology Research Center 57

The Espinosa Neuroscience Institute
801 Meadows Road, Suite 103
Boca Raton, FL 33486
Phone: (561) 788-7545
Fax: (561) 556-1216

Patricio Espinosa, MD, MPH, FAAN

Office Number: 561-788-7545
Email: Olivia Campbell, CRC

Translate »
Skip to content